JP2011509936A - 吸入薬物製品、システムおよび使用 - Google Patents

吸入薬物製品、システムおよび使用 Download PDF

Info

Publication number
JP2011509936A
JP2011509936A JP2010542367A JP2010542367A JP2011509936A JP 2011509936 A JP2011509936 A JP 2011509936A JP 2010542367 A JP2010542367 A JP 2010542367A JP 2010542367 A JP2010542367 A JP 2010542367A JP 2011509936 A JP2011509936 A JP 2011509936A
Authority
JP
Japan
Prior art keywords
drug product
chamber
fine particle
formulation
particle fraction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2010542367A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011509936A5 (enExample
Inventor
イン リー,
ジル ケー. シャーウッド,
バーバラ ハーバーリン,
イアン ローレンス スコット,
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of JP2011509936A publication Critical patent/JP2011509936A/ja
Publication of JP2011509936A5 publication Critical patent/JP2011509936A5/ja
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2010542367A 2008-01-10 2009-01-09 吸入薬物製品、システムおよび使用 Withdrawn JP2011509936A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2033308P 2008-01-10 2008-01-10
PCT/US2009/030562 WO2009089422A2 (en) 2008-01-10 2009-01-09 Inhalation drug products, systems and uses

Publications (2)

Publication Number Publication Date
JP2011509936A true JP2011509936A (ja) 2011-03-31
JP2011509936A5 JP2011509936A5 (enExample) 2012-12-06

Family

ID=40514046

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010542367A Withdrawn JP2011509936A (ja) 2008-01-10 2009-01-09 吸入薬物製品、システムおよび使用

Country Status (6)

Country Link
US (1) US20110182830A1 (enExample)
EP (1) EP2244692A2 (enExample)
JP (1) JP2011509936A (enExample)
CA (1) CA2711292A1 (enExample)
MX (1) MX2010007569A (enExample)
WO (1) WO2009089422A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201113662D0 (en) * 2011-08-08 2011-09-21 Prosonix Ltd Pharmaceutical compositions
CN115813935A (zh) * 2021-09-16 2023-03-21 上海上药信谊药厂有限公司 药物组合物、气雾剂及其制备方法和气雾剂产生系统

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI324934B (en) * 2001-08-28 2010-05-21 Schering Corp Pharmaceutical compositions for the treatment of asthma
US20080210225A1 (en) * 2007-03-01 2008-09-04 Rapha Institute For Health Disposable antistatic spacer

Also Published As

Publication number Publication date
EP2244692A2 (en) 2010-11-03
WO2009089422A2 (en) 2009-07-16
US20110182830A1 (en) 2011-07-28
MX2010007569A (es) 2011-03-21
CA2711292A1 (en) 2009-07-16
WO2009089422A3 (en) 2010-09-10

Similar Documents

Publication Publication Date Title
JP5170789B2 (ja) 喘息治療用の製薬組成物
AU2002313828A1 (en) Pharmaceutical compositions for the treatment of asthma
CN102665678B (zh) 用于copd的联合治疗
CA2677573A1 (en) Pharmaceutical combinations of at least two bronchodilators or of a bronchodilator with a corticosteroid
TW201609185A (zh) 溴化吡咯醣及福莫特羅組合之穩定加壓噴霧溶液組成物
IL225712A (en) Nose spray device at a measured dose
RS57269B1 (sr) Stabilna pod pritiskom kompozicija aerosolnog rastvora glikopironijum bromida i kombinacije formoterola
US20100095963A1 (en) Pharmaceutical compositions
JP2023546025A (ja) 加圧定量吸入器のための医薬製剤
EP2444080A2 (en) Stable Pharmaceutical Drug Aerosols
TW201119644A (en) Pharmaceutical aerosol formulations of formoterol and beclometasone dipropionate
US20120055469A1 (en) Stable pharmaceutical drug products
JP2011509936A (ja) 吸入薬物製品、システムおよび使用
WO2021146176A1 (en) Medicinal compositions for carbon dioxide based metered dose inhalers
EA048425B1 (ru) Фармацевтический состав для дозирующего аэрозольного ингалятора
HK1128428B (en) Pharmaceutical compositions for the treatment of asthma
HK1151987B (en) Pharmaceutical compositions for the treatment of asthma
HK1060972B (en) Pharmaceutical compositions for the treatment of asthma
SG178764A1 (en) Stable pharmaceutical drug aerosols

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111027

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20111027

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121016

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20130521